185 related articles for article (PubMed ID: 22009460)
41. Brain metastases in breast cancer: prognostic factors and management.
Lee SS; Ahn JH; Kim MK; Sym SJ; Gong G; Ahn SD; Kim SB; Kim WK
Breast Cancer Res Treat; 2008 Oct; 111(3):523-30. PubMed ID: 17990100
[TBL] [Abstract][Full Text] [Related]
42. Uncertain benefit from surgery in patients with lung metastases from breast carcinoma.
Planchard D; Soria JC; Michiels S; Grunenwald D; Validire P; Caliandro R; Girard P; Le Chevalier T
Cancer; 2004 Jan; 100(1):28-35. PubMed ID: 14692021
[TBL] [Abstract][Full Text] [Related]
43. Comparing the cost-effectiveness of two brain metastasis treatment modalities from a payer's perspective: stereotactic radiosurgery versus surgical resection.
Vuong DA; Rades D; van Eck AT; Horstmann GA; Busse R
Clin Neurol Neurosurg; 2013 Mar; 115(3):276-84. PubMed ID: 22705458
[TBL] [Abstract][Full Text] [Related]
44. Radiation therapy for brain metastases in breast cancer patients.
Aoyama H
Breast Cancer; 2011 Oct; 18(4):244-51. PubMed ID: 20458564
[TBL] [Abstract][Full Text] [Related]
45. Long-term survivors after gamma knife radiosurgery for brain metastases.
Kondziolka D; Martin JJ; Flickinger JC; Friedland DM; Brufsky AM; Baar J; Agarwala S; Kirkwood JM; Lunsford LD
Cancer; 2005 Dec; 104(12):2784-91. PubMed ID: 16288488
[TBL] [Abstract][Full Text] [Related]
46. Stereotactic radiosurgical treatment of parenchymal brain metastases from prostate adenocarcinoma.
Kim SH; Chao ST; Toms SA; Vogelbaum MA; Barnett GH; Suh JH; Weil RJ
Surg Neurol; 2008 Jun; 69(6):641-6; discussion 646. PubMed ID: 18262258
[TBL] [Abstract][Full Text] [Related]
47. Impact of time of day on outcomes after stereotactic radiosurgery for non-small cell lung cancer brain metastases.
Badiyan SN; Ferraro DJ; Yaddanapudi S; Drzymala RE; Lee AY; Silver SA; Dyk P; DeWees T; Simpson JR; Rich KM; Robinson CG
Cancer; 2013 Oct; 119(19):3563-9. PubMed ID: 23839874
[TBL] [Abstract][Full Text] [Related]
48. Prognostic factors for stereotactic radiosurgery-treated patients with cerebral metastasis: implications on randomised control trial design and inter-institutional collaboration.
Gonda DD; Kim TE; Goetsch SJ; Kawabe T; Watanabe S; Alksne JF; Hattangadi JA; Nitta M; Ott K; Hodgens DW; Carter BS; Yamamoto M; Chen CC
Eur J Cancer; 2014 Apr; 50(6):1148-58. PubMed ID: 24529832
[TBL] [Abstract][Full Text] [Related]
49. Cavity volume dynamics after resection of brain metastases and timing of postresection cavity stereotactic radiosurgery.
Atalar B; Choi CY; Harsh GR; Chang SD; Gibbs IC; Adler JR; Soltys SG
Neurosurgery; 2013 Feb; 72(2):180-5; discussion 185. PubMed ID: 23149969
[TBL] [Abstract][Full Text] [Related]
50. How many metastases can be treated with radiosurgery?
Yamamoto M; Kawabe T; Barfod BE
Prog Neurol Surg; 2012; 25():261-72. PubMed ID: 22236687
[TBL] [Abstract][Full Text] [Related]
51. Comparing Preoperative With Postoperative Stereotactic Radiosurgery for Resectable Brain Metastases: A Multi-institutional Analysis.
Patel KR; Burri SH; Asher AL; Crocker IR; Fraser RW; Zhang C; Chen Z; Kandula S; Zhong J; Press RH; Olson JJ; Oyesiku NM; Wait SD; Curran WJ; Shu HK; Prabhu RS
Neurosurgery; 2016 Aug; 79(2):279-85. PubMed ID: 26528673
[TBL] [Abstract][Full Text] [Related]
52. Impacts of HER2-overexpression and molecular targeting therapy on the efficacy of stereotactic radiosurgery for brain metastases from breast cancer.
Yomo S; Hayashi M; Cho N
J Neurooncol; 2013 Apr; 112(2):199-207. PubMed ID: 23296546
[TBL] [Abstract][Full Text] [Related]
53. Stereotactic radiosurgery for brain metastases: comparison of lung carcinoma vs. non-lung tumors.
Williams J; Enger C; Wharam M; Tsai D; Brem H
J Neurooncol; 1998 Mar; 37(1):79-85. PubMed ID: 9525842
[TBL] [Abstract][Full Text] [Related]
54. Outcomes and prognostic factors in women with 1 to 3 breast cancer brain metastases treated with definitive stereotactic radiosurgery.
Yang TJ; Oh JH; Folkert MR; Gupta G; Shi W; Zhang Z; Morikawa A; Seidman A; Brennan C; Yamada Y; Chan TA; Beal K
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):518-25. PubMed ID: 25194669
[TBL] [Abstract][Full Text] [Related]
55. A Survival Score for Patients Receiving Stereotactic Radiosurgery Alone for Brain Metastases from Breast Cancer.
Rades D; Dziggel L; Janssen S; Blanck O; Hornung D; Schild SE
Anticancer Res; 2016 Mar; 36(3):1073-6. PubMed ID: 26977000
[TBL] [Abstract][Full Text] [Related]
56. Radiosurgery with 20 Gy provides better local contol of 1-3 brain metastases from breast cancer than with lower doses.
Rades D; Huttenlocher S; Rudat V; Hornung D; Blanck O; Phuong PC; Khoa MT; Schild SE; Fischer D
Anticancer Res; 2015 Jan; 35(1):333-6. PubMed ID: 25550568
[TBL] [Abstract][Full Text] [Related]
57. Breast cancer brain metastases - A 12 year review of treatment outcomes.
De Ieso PB; Schick U; Rosenfelder N; Mohammed K; Ross GM
Breast; 2015 Aug; 24(4):426-33. PubMed ID: 25881974
[TBL] [Abstract][Full Text] [Related]
58. The volumetric response of brain metastases after stereotactic radiosurgery and its post-treatment implications.
Sharpton SR; Oermann EK; Moore DT; Schreiber E; Hoffman R; Morris DE; Ewend MG
Neurosurgery; 2014 Jan; 74(1):9-15; discussion 16; quiz 16. PubMed ID: 24077581
[TBL] [Abstract][Full Text] [Related]
59. Initial SRS for Patients With 5 to 15 Brain Metastases: Results of a Multi-Institutional Experience.
Hughes RT; Masters AH; McTyre ER; Farris MK; Chung C; Page BR; Kleinberg LR; Hepel J; Contessa JN; Chiang V; Ruiz J; Watabe K; Su J; Fiveash JB; Braunstein S; Chao S; Attia A; Ayala-Peacock DN; Chan MD
Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1091-1098. PubMed ID: 30959122
[TBL] [Abstract][Full Text] [Related]
60. Is stereotactic radiosurgery under-utilised in the treatment of surgically excisable cerebral metastases?
Lee MK; Javadpour M; Jenkinson MD
Br J Neurosurg; 2013 Oct; 27(5):658-61. PubMed ID: 23659198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
